Search results for “SCLC - Small cell lung cancer” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 629 patents, we discovered top 193 key players by total patent application. AstraZeneca Pharmaceutical Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., MedImmune Ltd. are dominant in this area. They take 12.72% of the total patent filing.
Jiangsu Sheng, China
Patent: 32
Jiangsu Sheng, China
Patent: 28
Cambridgeshire, United Kingdom
Patent: 20
California, United States
Patent: 18
Basel-Stadt, Switzerland
Patent: 17
Indiana, United States
Patent: 17
California, United States
Patent: 17
Guangdong Sheng, China
Patent: 15
Baden-Württemberg, Germany
Patent: 14
Hessen, Germany
Patent: 14
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 13 patents, we discovered top 8 start-ups by total patent application. OrigiMed (Shanghai) Co., Ltd., Wellmarker Bio Co., Ltd., Bluefin Biomedicine, Inc. are active in this area.
STARTUP
Shanghai Shi, China
Patent: 4
STARTUP
South Korea
Patent: 2
STARTUP
Massachusetts, United States
Patent: 2
STARTUP
Massachusetts, United States
Patent: 1
STARTUP
Massachusetts, United States
Patent: 1
STARTUP
Massachusetts, United States
Patent: 1
STARTUP
Osaka-fu, Japan
Patent: 1
STARTUP
New Jersey, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 620 patents applied in the last 5 years. We discover 270 most active companies in this area. The fast-growing AstraZeneca Pharmaceutical Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Shenzhen Chipscreen Biosciences Co., Ltd. take 10.81% of patent filing during this period.
Jiangsu Sheng, China
Patent: 32
Jiangsu Sheng, China
Patent: 20
Guangdong Sheng, China
Patent: 15
Hessen, Germany
Patent: 12
New York, United States
Patent: 12
California, United States
Patent: 11
New York, United States
Patent: 10
Beijing Shi, China
Patent: 9
Baden-Württemberg, Germany
Patent: 9
Shanghai Shi, China
Patent: 9
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 620 patents in last 5 years, we discover 227 new entrants. AstraZeneca Pharmaceutical Co., Ltd., Shenzhen Chipscreen Biosciences Co., Ltd., Iovance Biotherapeutics, Inc. are the most active new entrants in this area.
Jiangsu Sheng, China
Patent: 32
Guangdong Sheng, China
Patent: 15
New York, United States
Patent: 12
New York, United States
Patent: 10
Beijing Shi, China
Patent: 9
Shanghai Shi, China
Patent: 9
California, United States
Patent: 8
California, United States
Patent: 7
Shandong Sheng, China
Patent: 7
Shanghai Shi, China
Patent: 7
Research Institutions
Order by:
Innovation Intensity
With the analysis among 224 patents, we discovered top 98 universities and scientific research institutions by total patent application. China Pharmaceutical University, Shanghai Institute of Materia Medica Chinese Academy of Sciences, University of British Columbia are dominant in this area. They take 10.27% of the total patent filing.
Jiangsu Sheng, China
Patent: 6
Shanghai Shi, China
Patent: 6
British Columbia, Canada
Patent: 5
Shanghai Shi, China
Patent: 5
Shanghai Shi, China
Patent: 5
New York, United States
Patent: 4
New York, United States
Patent: 3
Tokyo-to, Japan
Patent: 3
Zhejiang Sheng, China
Patent: 3
Zhejiang Sheng, China
Patent: 3
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: